IFP Advisors’s AnaptysBio ANAB Stock Holding History

IFP Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$68	Hold	1	–	–	﹤0.01%	4998
2026 Q1	$55	Hold	1	–	–	﹤0.01%	4818
2025 Q4	$48	Hold	1	–	–	﹤0.01%	4708
2025 Q3	$31	Buy	+1	New	+$23	﹤0.01%	4716
2025 Q2	–	Hold	0	–	–	–	4481
2024 Q4	–	Hold	0	–	–	–	4410
2023 Q3	–	Sell	-18	Closed	-$366	–	3304
2023 Q2	$366	Hold	18	–	–	﹤0.01%	3244
2023 Q1	$1.38K	Sell	18 -3	-14%	-$73	﹤0.01%	3006
2022 Q4	$2K	Buy	21 +3	+17%	+$85	﹤0.01%	4106
2022 Q3	$1K	Buy	+18	New	+$422	﹤0.01%	4492
2020 Q1	–	Sell	-20	Closed	-$303	–	2761
2019 Q4	$0	Buy	+20	New	+$473	﹤0.01%	2832
2018 Q4	–	Sell	-14	Closed	-$1K	–	3510
2018 Q3	$1K	Buy	+14	New	+$1.16K	﹤0.01%	3642

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

IFP Advisors's ANAB Position: Q2 2026 in Review

IFP Advisors held its AnaptysBio (ANAB) position steady in Q2 2026 at 1 share worth $68. The position accounts for ﹤0.01% of the portfolio, ranked #4998.

IFP Advisors first reported a position in ANAB in Q3 2018 and has held it in 10 quarters since. The position peaked at $2K in Q4 2022. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

IFP Advisors held 1 share of AnaptysBio worth $68 as of Q2 2026.
IFP Advisors left its AnaptysBio share count unchanged in Q2 2026.
AnaptysBio made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4998 holding.
IFP Advisors first reported a position in AnaptysBio in Q3 2018 and has held it in 10 quarters since.
IFP Advisors's AnaptysBio position peaked at $2K in Q4 2022.
213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.